182 related articles for article (PubMed ID: 28218345)
41. Are patients with skin cancer at lower risk of developing colorectal or breast cancer?
Soerjomataram I; Louwman WJ; Lemmens VE; Coebergh JW; de Vries E
Am J Epidemiol; 2008 Jun; 167(12):1421-9. PubMed ID: 18424428
[TBL] [Abstract][Full Text] [Related]
42. Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases.
van den Reek JM; van Lümig PP; Janssen M; Schers HJ; Hendriks JC; van de Kerkhof PC; Seyger MM; de Jong EM
J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):27-33. PubMed ID: 23216663
[TBL] [Abstract][Full Text] [Related]
43. Incidence and risk factors for nonmelanoma skin cancer after heart transplantation.
Molina BD; Leiro MG; Pulpón LA; Mirabet S; Yañez JF; Bonet LA; Vilchez FG; Delgado JF; Manito N; Rábago G; Arizón JM; Romero N; Roig E; Blasco T; Pascual D; de la Fuente L; Muñiz J
Transplant Proc; 2010 Oct; 42(8):3001-5. PubMed ID: 20970593
[TBL] [Abstract][Full Text] [Related]
44. Analysis of non-melanoma skin cancer across the tofacitinib rheumatoid arthritis clinical programme.
Curtis JR; Lee EB; Martin G; Mariette X; Terry KK; Chen Y; Geier J; Andrews J; Kaur M; Fan H; Nduaka CI
Clin Exp Rheumatol; 2017; 35(4):614-622. PubMed ID: 28240592
[TBL] [Abstract][Full Text] [Related]
45. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
Ng JC; Cumming S; Leung V; Chong AH
Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
[TBL] [Abstract][Full Text] [Related]
46. Incidence of non-melanoma skin cancer in patients treated with psoralen and ultraviolet A therapy.
Ortiz Salvador JM; Pérez-Ferriols A; Alegre de Miquel V; Saneleuterio Temporal M; Vilata Corell JJ
Med Clin (Barc); 2019 Jun; 152(12):488-492. PubMed ID: 30503067
[TBL] [Abstract][Full Text] [Related]
47. An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.
van Lümig PP; Menting SP; van den Reek JM; Spuls PI; van Riel PL; van de Kerkhof PC; Fransen J; Kievit W; de Jong EM
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):752-60. PubMed ID: 25229823
[TBL] [Abstract][Full Text] [Related]
48. Oral prednisone use and risk of keratinocyte carcinoma in non-transplant population. The VATTC trial.
Baibergenova AT; Weinstock MA;
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1109-15. PubMed ID: 21923839
[TBL] [Abstract][Full Text] [Related]
49. Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial.
Clouser MC; Roe DJ; Foote JA; Harris RB
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):276-83. PubMed ID: 19226541
[TBL] [Abstract][Full Text] [Related]
50. Azathioprine and risk of multiple keratinocyte cancers.
Cho HG; Kuo KY; Xiao K; Batra P; Li S; Tang JY; Sarin KY
J Am Acad Dermatol; 2018 Jan; 78(1):27-28.e1. PubMed ID: 28989107
[No Abstract] [Full Text] [Related]
51. Risk factors for non-melanoma skin cancer development in renal transplant recipients: a 40 year retrospective study in Croatia.
Bašić-Jukić N; Borlinić T; Tešanović D; Mokos I; Krešimir Lukić I; Bukvić Mokos Z
Croat Med J; 2022 Apr; 63(2):148-155. PubMed ID: 35505648
[TBL] [Abstract][Full Text] [Related]
52. Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
McLaughlin JM; Equils O; Somerville KT; Aram JA; Schlamm HT; Welch VL; Mardekian J; Barbers RG
Transpl Infect Dis; 2013 Aug; 15(4):329-43. PubMed ID: 23489832
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
Stern RS
Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
[TBL] [Abstract][Full Text] [Related]
54. Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-αIs), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidence.
Nardone B; Orrell KA; Vakharia PP; West DP
Expert Opin Drug Saf; 2018 Feb; 17(2):139-147. PubMed ID: 29103328
[TBL] [Abstract][Full Text] [Related]
55. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
Hoy WE
Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
[TBL] [Abstract][Full Text] [Related]
56. Use of antiepileptic drugs and risk of skin cancer: A nationwide case-control study.
Kristensen KB; Pedersen SA; Schmidt SAJ; Pottegård A
J Am Acad Dermatol; 2020 Feb; 82(2):326-335. PubMed ID: 31150714
[TBL] [Abstract][Full Text] [Related]
57. Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis.
Fowler E; Rosen J; Lev-Tov H; Yosipovitch G
Acta Derm Venereol; 2019 Sep; 99(10):899-900. PubMed ID: 31037315
[No Abstract] [Full Text] [Related]
58. Skin cancer following kidney transplantation: a single-center experience.
Karczewski M; Stronka M; Karczewski J; Wiktorowicz K
Transplant Proc; 2011 Dec; 43(10):3760-1. PubMed ID: 22172842
[TBL] [Abstract][Full Text] [Related]
59. Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs.
Bakker DS; Garritsen FM; Leavis HL; van der Schaft J; Bruijnzeel-Koomen CAFM; van den Broek MPH; de Bruin-Weller MS
J Dermatolog Treat; 2018 Nov; 29(7):682-687. PubMed ID: 29526121
[TBL] [Abstract][Full Text] [Related]
60. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]